SE452251B - Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi - Google Patents

Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi

Info

Publication number
SE452251B
SE452251B SE8602841A SE8602841A SE452251B SE 452251 B SE452251 B SE 452251B SE 8602841 A SE8602841 A SE 8602841A SE 8602841 A SE8602841 A SE 8602841A SE 452251 B SE452251 B SE 452251B
Authority
SE
Sweden
Prior art keywords
test
test substance
patches
film
complex
Prior art date
Application number
SE8602841A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602841D0 (sv
Inventor
B Resul
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8602841A priority Critical patent/SE452251B/sv
Publication of SE8602841D0 publication Critical patent/SE8602841D0/xx
Priority to AU73835/87A priority patent/AU7383587A/en
Priority to ES87850190T priority patent/ES2001745A4/es
Priority to EP87850190A priority patent/EP0252044A1/en
Priority to DE198787850190T priority patent/DE252044T1/de
Priority to JP62158776A priority patent/JPS6317832A/ja
Publication of SE452251B publication Critical patent/SE452251B/sv
Priority to GR88300064T priority patent/GR880300064T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0035—Vaccination diagnosis other than by injuring the skin, e.g. allergy test patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B2010/0003—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
    • A61B2010/0006—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person involving a colour change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Strength Of Materials By Application Of Mechanical Stress (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8602841A 1986-06-26 1986-06-26 Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi SE452251B (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8602841A SE452251B (sv) 1986-06-26 1986-06-26 Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi
AU73835/87A AU7383587A (en) 1986-06-26 1987-06-04 Test strip and method for epicutaneous testing
ES87850190T ES2001745A4 (es) 1986-06-26 1987-06-11 Tira de ensayo y metodo para llevar a cabo pruebas epicutaneas
EP87850190A EP0252044A1 (en) 1986-06-26 1987-06-11 Test strip and method for epicutaneous testing
DE198787850190T DE252044T1 (de) 1986-06-26 1987-06-11 Teststreifen und methode fuer einen epikutantest.
JP62158776A JPS6317832A (ja) 1986-06-26 1987-06-25 テストストリツプ及び皮上テスト
GR88300064T GR880300064T1 (en) 1986-06-26 1988-05-20 Test strip and method for epicutaneous testing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8602841A SE452251B (sv) 1986-06-26 1986-06-26 Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi

Publications (2)

Publication Number Publication Date
SE8602841D0 SE8602841D0 (sv) 1986-06-26
SE452251B true SE452251B (sv) 1987-11-23

Family

ID=20364928

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602841A SE452251B (sv) 1986-06-26 1986-06-26 Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi

Country Status (7)

Country Link
EP (1) EP0252044A1 (ja)
JP (1) JPS6317832A (ja)
AU (1) AU7383587A (ja)
DE (1) DE252044T1 (ja)
ES (1) ES2001745A4 (ja)
GR (1) GR880300064T1 (ja)
SE (1) SE452251B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009184A1 (en) * 1987-05-25 1988-12-01 Pharmacia Ab Test patch and its use for demonstrating contact allergy

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802403D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Alster att anvendas vid ocklusiv epikutantestning for att pavisa kontaktallergi mot formaldehyd
GB2239708A (en) * 1989-08-24 1991-07-10 Sam Shuster Allergy patch testing
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
JP4947007B2 (ja) * 2008-08-07 2012-06-06 トヨタ自動車株式会社 過給機付き内燃機関
US20110306898A1 (en) * 2010-06-09 2011-12-15 Michael Stierstorfer IBS Related Testing and Treatment
US20140241995A1 (en) * 2011-06-29 2014-08-28 Hds Ltd. Micropatch for assessing chemical contact allergy
GB2492361A (en) * 2011-06-29 2013-01-02 Hds Ltd Micropatch for contact allergy testing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE318060B (ja) * 1966-08-11 1969-12-01 G Fregert
US3734097A (en) * 1969-04-01 1973-05-22 Alza Corp Therapeutic adhesive tape
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
US3703890A (en) * 1970-08-10 1972-11-28 Milton A Saunders Jr Skin patch test device
FI52268C (fi) * 1973-03-15 1977-08-10 Veikko Paavo Pirilae Ihotestin kate.
FR2375861A1 (fr) * 1976-12-31 1978-07-28 Merieux Inst Tampon adhesif pour tests epicutanes
SE443914B (sv) * 1984-10-01 1986-03-17 Torkel Ingemar Fischer Medel for en overkenslighetstest

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009184A1 (en) * 1987-05-25 1988-12-01 Pharmacia Ab Test patch and its use for demonstrating contact allergy

Also Published As

Publication number Publication date
SE8602841D0 (sv) 1986-06-26
ES2001745A4 (es) 1988-06-16
EP0252044A1 (en) 1988-01-07
JPS6317832A (ja) 1988-01-25
GR880300064T1 (en) 1988-10-18
AU7383587A (en) 1988-01-07
DE252044T1 (de) 1988-09-01

Similar Documents

Publication Publication Date Title
AU573917B2 (en) Occlusive epicutaneous(patch) tests
US5904929A (en) Acylated cyclodextrin-containing pharmaceutical composition
Thakur et al. Formulation and evaluation of transdermal composite films of chitosan-montmorillonite for the delivery of curcumin
SE452251B (sv) Testremsa avsedd att anvendas vid ocklusiv epikutantest for att pavisa kontaktallergi
WO2003033025A2 (en) Cyclodextrin complexes
FR2717688A1 (fr) Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
Mamatha et al. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization
CN101330908B (zh) 粘贴制剂
Ersen Dudu et al. Application of poly (Agar-co-glycerol-co-sweet almond oil) based organo-hydrogels as a drug delivery material
AU606973B2 (en) Sustained-release percutaneous preparations
Nayak et al. Formulation design preparation and in vitro characterization of nebivolol transdermal patches
JPH02500748A (ja) 有効成分の経皮性吸収が確実な医薬製剤およびその製法
Sciarra et al. Evaluation of selected physical constants of polymeric films and proposed kinetics of drug release
JP2860423B2 (ja) 接触アレルギーを示すための試験パッチ
Jatav et al. Effect of dimethyl sulphoxides as permeation enhancer on transdermal patch of nebivolol hydrochloride
EP1865931A1 (en) Transdermal patch
Gupta et al. Preparation and characterization of gelatin-poly (methacrylic acid) interpenetrating polymeric network hydrogels as a pH-sensitive delivery system for glipizide
JP2001122772A (ja) 含水系粘着組成物及びパップ剤
Suksaeree et al. Formulation development of matrix type transdermal patches containing mefenamic acid: physicochemical characterization and in vitro release evaluation
Lal Development and evaluation of transdermal therapeutic system of metoprolol succinate using acrylic polymer
Nakhle et al. Cyclodextrin polymers in combination with water and deep eutectic solvent for the retention of Eucalyptus citriodora essential oil
Adhyapak et al. Preparation and in vitro characterization of the transdermal drug delivery system containing tamoxifen citrate for breast cancer
JP4446649B2 (ja) 発熱性貼付剤
Tariq et al. Cellulosic and acrylic polymers based composites for controlled drug release
Solanki et al. Formulation Development and Evaluation of Mucoadhesive Buccal Patches of Metoprolol Tartrate

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602841-2

Effective date: 19910131

Format of ref document f/p: F